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Cyclodipeptide synthases form cyclodipeptides from two aminoacyl transfer RNAs. They use
a ping-pong mechanism that begins with transfer of the aminoacyl moiety of the ﬁrst
aminoacyl tRNA onto a conserved serine, yielding an aminoacyl enzyme. Combining X-ray
crystallography, site-directed mutagenesis and afﬁnity labelling of the cyclodipeptide
synthase AlbC, we demonstrate that the covalent intermediate reacts with the aminoacyl
moiety of the second aminoacyl tRNA, forming a dipeptidyl enzyme, and identify the
aminoacyl-binding sites of the aminoacyl tRNAs.
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C
yclodipeptide synthases (CDPSs) are a novel family of
enzymes that hijack aminoacyl tRNAs (aa-tRNAs) from
their canonical function in ribosomal protein synthesis to
produce various cyclodipeptides, which are precursors of many
secondary metabolites with diverse biological activities1–3. They
employ a ping-pong-type catalytic mechanism beginning with the
binding of a ﬁrst aa-tRNA and the transfer of its aminoacyl
moiety onto a conserved serine leading to the formation of an
aminoacyl enzyme intermediate4–7. The subsequent steps of the
catalytic mechanism have not yet been elucidated. It has been
proposed that the aminoacyl enzyme reacts with the aminoacyl
moiety of a second aa-tRNA to form either a dipeptidyl enzyme6
or a dipeptidyl tRNA intermediate5, which undergoes
intramolecular cyclization to generate the ﬁnal cyclodipeptide
product (Fig. 1). Neither of these two putative intermediates has
ever been detected directly.
The crystal structures of three CDPSs have been determined:
AlbC from Streptomyces noursei, Rv2275 from Mycobacterium
tuberculosis and YvmC from Bacillus licheniformis4–6. These
enzymes possess a common architecture very similar to the
catalytic domains of class-I aa-tRNA synthetases (aaRSs),
especially class-Ic TyrRSs and TrpRSs. In particular, the
aminoacyl moiety of the ﬁrst aa-tRNA substrate of CDPS is
thought to bind in a pocket4–7, structurally corresponding to the
tyrosine-binding pocket in TyrRSs (PDB 1J1U8). Accordingly,
buffer components were identiﬁed within this pocket in several
CDPS crystal structures4,6. However, no structure of a CDPS in
complex with either a natural substrate or a ligand representative
of a reaction intermediate has been obtained.
Here we present the ﬁrst crystal structure of a CDPS
complexed with a reaction intermediate analogue. This structure,
combined with site-directed mutagenesis and chemical biology
experiments, reveals that the second reaction intermediate is a
dipeptidyl enzyme. We map the aminoacyl-binding sites for each
of the two aa-tRNA substrates. Finally, we identify the residue
responsible for the intramolecular cyclization of the dipeptidyl
intermediate and revisit the roles of the other active site residues.
Results
We reasoned that the identiﬁcation of the second reaction
intermediate would be facilitated by blocking the enzymatic
reaction before dipeptide cyclization. To identify residues possibly
involved in cyclization, we ﬁrst determined the crystal structure of
a complex mimicking a putative dipeptidyl AlbC intermediate.
AlbC synthesizes cyclo(L-Phe-L-Leu) (cFL) and cyclo(L-Phe-L-Phe)
(cFF)2, and its S37 residue is the target for phenylalanylation4
(Fig. 1). Therefore, if a dipeptidyl enzyme intermediate indeed
occurs, it should be composed of a dipeptide covalently linked by
its carboxylate terminus to the S37 hydroxyl. To obtain a structural
analogue of L-Phe-L-Phe-AlbC, we used N-carbobenzyloxy-L-Phe-
chloromethyl ketone (ZPCK) (Fig. 2a), a molecule close to the Phe-
Phe dipeptide (Fig. 1). We used the active AlbC variant S37C4 as a
target for ZPCK labelling, because the chloromethyl ketone in this
analogue is able to react with thiol groups (Fig. 2a). As expected,
trypsin digestion and peptide mass ﬁngerprinting (PMF) showed
that C37 was covalently modiﬁed after incubation of AlbC S37C
with ZPCK (Supplementary Fig. 1).
We solved the structure of the modiﬁed AlbC S37C, named
AlbC S37C-ZPK (ZPK corresponds to N-carbobenzyloxy-L-Phe-
methyl ketone), by molecular replacement using the previously
determined unmodiﬁed AlbC structure (PDB 3OQV). The
resulting electron density map showed a supplementary mass of
electron density connected to C37, and some rearrangements in
the structure of the enzyme. The supplementary density clearly
corresponded to ZPK (Supplementary Fig. 2). The structure was
reﬁned at 2.9 Å resolution after a few cycles of model ﬁtting and
energy minimization (Table 1). The structural model consists of
the entire AlbC S37C enzyme bound to ZPK (Fig. 2b), excluding
residues 1–9 and residues 234–239 at the C-terminal extremity
for which no electron density was visible. Overall, the AlbC S37C-
ZPK structure is highly similar to the unmodiﬁed AlbC structure
(root mean squared deviation¼ 0.9 Å over 169 Ca,
Supplementary Figs 3 and 4). However, the region linking the
b6 and b7 strands, in the vicinity of the ZPCK binding site, is
rearranged (residues 202–225). The 202–207 loop and a8
(residues 208–213) are pushed away from the active site cavity
in the AlbC S37C-ZPK structure (Fig. 2b and Supplementary
Figs 3 and 4). In the structure of unmodiﬁed AlbC (PDB 3OQV),
Y202 and neighbouring residues are involved in crystal packing
(Supplementary Fig. 5). Therefore, the conformational difference
of the 202–225 region between AlbC S37C-ZPK and unmodiﬁed
AlbC cannot be attributed to modiﬁcation by ZPK. Notably, the
conformation of this region in AlbC S37C-ZPK appears close to
that observed in Rv2275 and YvmC (PDB 2X9Q and 3OQJ,
respectively; Supplementary Fig. 4).
The aromatic ring (Phe1) of ZPK is buried deep within a
hydrophobic pocket, corresponding to that occupied by cyclo-
dithiothreitol in the AlbC structure4, or by the buffer components
CHES or CAPSO in the structure of YvmC6. The cavity is
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Figure 1 | Formation of cyclo(L-Phe-L-Phe) catalysed by the CDPS AlbC. The existence of the phenylalanyl AlbC intermediate was demonstrated
previously4, but the nature of the dipeptidyl intermediate was unknown.
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delineated on one side by strands b3, b4 and b6, and on the other
side by helix a8. In particular, there is a stacking interaction
between F186 and the Phe1 ring (Fig. 2c). In the S37C-ZPK
structure, the benzyl ring (Phe2) lies in a wider cavity delineated
by two loops, hereafter named CL1 and CL2 (catalytic loop 1:
residues 36–43; catalytic loop 2: residues 202–207), the
C-terminal part of a6 (152–159) and the central part of a7
(175–183) (Fig. 2d). Stacking interactions involving Y42, H203
and Y202, and a water-mediated interaction between N40 and
H203, stabilize the positions of the two catalytic loops. Notably, in
AlbC S37C-ZPK the position of CL1 and CL2 places the side
chain of Y202 in proximity to ZPK (Fig. 2c,d).
We derived a model of the dipeptidyl enzyme from the AlbC
S37C-ZPK structure (Fig. 2e and Supplementary Fig. 6) and used
it to identify residues possibly involved in dipeptide cyclization.
The intramolecular cyclization of the dipeptide ester requires that
the dipeptide be in a cis conformation to place the primary
ammonium group in close proximity to the ester9,10. The
conformation adopted by the dipeptide places the ammonium
group of Phe2 near the ester carbonyl (2.3 Å), which is in line
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Figure 2 | Afﬁnity labelling of AlbC and crystal structure of a complex mimicking the dipeptidyl enzyme intermediate. (a) The AlbC variant S37C
was covalently modiﬁed with N-carbobenzyloxy-L-Phe-chloromethyl ketone (ZPCK). The labelled CDPS was named AlbC S37C-ZPK. (b) Cartoon
representation of the structure of AlbC S37C-ZPK (PDB 4Q24). Secondary structure elements are labelled. The protein is shown in grey as a semi-
transparent molecular surface. Regions surrounding the ZPK adduct are coloured as follows: CL1 and CL2 (CL1: 33–43, CL2: 202–207), and the N terminus
of b3,4,6 are in yellow. Parts of a6 (151–159) and a7 (172–182) are in pink. Phe1 is buried deep within its cavity, whereas Phe2 lies in a wide pocket.
(c) Close-up view of the Phe1-binding site. The ZPK adduct is shown as green sticks within its molecular surface. Residues delineating the cavities are
shown as sticks; catalytic residues are labelled in orange. Yellow is used for b-strands and pink for helix a8. Relevant interactions are indicated with a
dashed line. (d) Close-up view of the Phe2-binding site. Yellow is used for CL1 and CL2, and pink for a6 and a7. Important residues are shown as sticks;
catalytic residues are labelled in orange. This view highlights stacking interactions between Y42, H203 and Y202, and a water-mediated interaction
between N40 and H203 that stabilize the positions of CL1 and CL2. Notably, a water molecule is present at the same position in the active site of Rv2275.
Y178, E182 and Y202 are in close proximity to ZPK. Hydrogen bonds between Y178 and E182 are indicated with dashed lines. (e) Model of the
diphenylalanyl enzyme. Position of the diphenylalanyl adduct was modelled according to the position of the ZPK adduct (Supplementary Fig. 6). The
diphenylalanyl adduct was constructed with the REEL and eLBOW programmes from the Phenix suite28. Important regions involved in the binding of the
dipeptide are in yellow and pink. The dipeptide intermediate is shown as orange sticks. Important residues are shown as sticks. According to this model, the
oxygen group of Y202 is positioned 3.1 Å away from the NH2 group of the dipeptide. All structural drawings were done with PYMOL (www.pymol.org).
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with this requirement (Fig. 2e and Supplementary Fig. 6). This
primary ammonium group should be deprotonated by a catalytic
base to generate the nucleophile for attack at the activated ester.
The conserved Y202 residue is a good candidate to fulﬁll this role,
because its hydroxyl would be close to the ammonium group of
Phe2 (3.1 Å) (Fig. 2e and Supplementary Fig. 6). Such a role for a
Y residue is unusual but has already been described11–13. In
Rv2275 and YvmC, this residue was initially proposed to position
and increase the nucleophilicity of the catalytic serine5,6.
However, we showed previously that its substitution with a
phenylalanine in AlbC did not affect the formation of the
aminoacyl enzyme intermediate, demonstrating that Y202 is not
responsible for the activation of the catalytic serine4. The Y202
hydroxyl is nevertheless essential, because the Y202F variant has
20-fold lower enzymatic activity than the wild-type enzyme,
although its structural integrity is not affected (Supplementary
Table 1 and Supplementary Fig. 7). We hypothesized that the
modiﬁcation of Y202 to F may impair the cyclization process,
allowing the trapping of the dipeptidyl enzyme if it indeed occurs.
We incubated brieﬂy the Y202F variant with two equivalents of
Phe-tRNAPhe and immediately analysed the resulting species by
liquid chromatography–mass spectrometry (LC–MS) or PMF.
LC–MS analysis showed a mixture of three species, with masses
consistent with the unmodiﬁed AlbC Y202F, a phenylalanyl
enzyme and a diphenylalanyl enzyme (Supplementary Fig. 8).
Previous PMF analyses of trypsin-digested AlbC and of its Y202F
variant gave two fragments containing the catalytic S37
(fragments [29–46] and [27–46])4 (Supplementary Fig. 9). The
PMF analysis of Y202F incubated with two equivalents of Phe-
tRNAPhe gave the [27–46] fragment, low amounts of the [29–46]
fragment and two additional fragments (Fig. 3). The m/z of these
two fragments were 2,310.17 and 2,457.2, and corresponded to
the values expected for the addition of phenylalanyl and
diphenylalanyl moieties on fragment [27–46], respectively. We
sequenced unambiguously by both b- and y-series the fragment
with an m/z of 2,457.2, which showed that it contained a
diphenylalanyl adduct on S37. This experiment thus
demonstrates the formation of the covalent dipeptidyl enzyme
intermediate. Moreover, we did not observe the diphenylalanyl
adduct with wild-type AlbC; therefore, we conclude that Y202 is
involved in the cyclization process, probably by deprotonating the
primary ammonium group.
The AlbC S37C-ZPK structure allowed us to revisit the role of
other active site residues and propose the following catalytic
mechanism (Fig. 4). When the ﬁrst Phe-tRNAPhe binds, the
phenylalanyl side chain is accommodated in the catalytic pocket
and both amino and carbonyl groups are appropriately positioned
through hydrogen bonds with the side chains of E182 and Y178
(Step 1). The Y178 hydroxyl polarizes the incoming ester
carbonyl of the ﬁrst aa-tRNA and facilitates the nucleophilic
attack by the S37 hydroxyl. S37 activation probably results from a
concerted proton shufﬂing mechanism involving the two adjacent
vicinal hydroxyls of the nucleotide A76 of the tRNA moiety4, as
proposed for the ribosome at the peptidyl transferase centre14 and
the FemX aa-transferase of Weissella viridescens15. Then, the
Y178 hydroxyl may help to stabilize the resulting phenylalanyl
enzyme intermediate (Step 2). This is consistent with our
structural data, indicating that Y178 is engaged in a polar
contact with the carbonyl of Phe1 (Fig. 2d), and our previous
ﬁnding showing that the Y178F substitution substantially impairs
both enzymatic activity and the formation of the phenylalanyl
enzyme intermediate4. Such a role for a Y hydroxyl has been
described previously for prolyl oligopeptidase16 and cocaine
esterase17. Next, the second Phe-tRNAPhe binds (Step 3). The
formation of the subsequent diphenylalanyl enzyme intermediate
implies that the ammonium group of the phenylalanyl enzyme
intermediate has to be deprotonated by a catalytic base to
perform the nucleophilic attack on the incoming carbonyl of the
second substrate. The nearby E182 may fulﬁll this role13,18,19.
This residue is essential to the catalytic reaction and is involved in
catalytic steps following amino-acyl formation4–6. Thus, the
ammonium group of the ﬁrst phenylalanine, deprotonated by
the nearby carboxyl of E182, may attack the carbonyl group of
the second Phe-tRNAPhe to generate a diphenylalanyl enzyme
intermediate (Step 4). The carboxyl of E182 now in its protonated
state may form electrostatic contacts with the two carbonyls of
the dipeptide, similar to those we observed in the AlbC S37C-
ZPK structure (Fig. 2c). The successive protonation states of E182
are supported further by pKa predictions made with the heuristic
pKa calculation software PROPKA20 (pKa values of 7.8 in free
AlbC, 4.8 in the aminoacyl enzyme and 7.5 in AlbC S37C-ZPK).
Thus, E182 and Y178 form hydrogen bonds with the dipeptide,
precisely holding its backbone in the conformation required for
cyclization. Y202 is then properly positioned to deprotonate the
ammonium group of the second amino acid. Y202 participates in
a hydrogen bond network, also involving N40 and H203, which
are essential for the accurate positioning of catalytic residues. The
substitution of either residue with alanine resulted in a dramatic
impairment of enzymatic activity (Supplementary Table 1) and
phenylalanyl enzyme formation (Supplementary Fig. 10), whereas
the structural integrity of the variants was not affected
(Supplementary Fig. 7). Finally, Y202 would deprotonate the
primary ammonium group to generate the nucleophile for attack
at the enzyme ester bond (Step 5), leading to the formation of the
cyclodipeptide product.
The AlbC-ZPK structure enables the identiﬁcation of the two
pockets P1 and P2 accommodating the aminoacyl moieties of
the ﬁrst and second aa-tRNA, respectively (Fig. 2c,d). We
compared the residues lining P1 and P2 in all characterized
CDPSs together with the cyclodipeptides that these enzymes
Table 1 | Data collection and reﬁnement statistics for AlbC
S37C-ZPK structure determination.
Native*
Data collection
Space group P3221
Cell dimensions
a, b, c (Å) 86.97, 86.97, 70.74
a, b, g () 90.0, 90.0, 120.0
Resolution (Å) 37.66, 2.9
Rsym 0.078 (0.618)
w
I/sI 11.45 (1.75)
Completeness (%) 98.1% (98.5)
Redundancy 2.71 (2.72)
Reﬁnement
Resolution (Å) 37.66, 2.9
No. reﬂections 7001
Rwork/Rfree 0.2007/0.2526
No. atoms
Protein 1,773
Modiﬁed residue 28
Waters 3
B-factors (Å2) Protein 71
Modiﬁed residue 75
Waters 54
Root mean squared deviations
Bond lengths (Å) 0.009
Bond angles () 1.07
*A single crystal was used for data collection.
wValues in brackets correspond to the highest-resolution shell.
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produce (Supplementary Table 2 and Supplementary Fig. 11). P1
has a hydrophobic character, in keeping with the accommoda-
tion of hydrophobic amino acids. Our structural data show that
P2 is wider than P1, consistent with a somewhat relaxed
speciﬁcity for the second aminoacyl moiety. In line with this
idea, the amino acids lining P2 are poorly conserved
(Supplementary Table 2).
Discussion
This study, combining structural approaches and chemical
biology experiments, elucidates the missing step in the mechan-
ism of the recently discovered CDPSs—the formation of a
dipeptidyl enzyme.
Our work also identiﬁes two different binding sites for the
aminoacyl moieties of the two aa-tRNA substrates. We previously
identiﬁed two different regions accommodating the tRNA
moieties of the substrates21. Taken together, these data provide
insight into the molecular basis of the interaction between CDPSs
and their substrates. The ﬁrst aa-tRNA binds to the enzyme
through the accommodation of its aminoacyl moiety in the P1
pocket and the interaction of its tRNA moiety with basic residues
located in the a4 helix that form a basic patch at the surface of the
protein. When the acyl enzyme is formed, the second aa-tRNA
binds with its aminoacyl moiety accommodated in the P2 pocket
and its tRNA moiety interacting with residues of the a6–a7 loop.
In both TyrRS and TrpRS, the loop equivalent to this a6–a7 loop
is involved in tRNA binding8,22–24. CDPSs may have retained
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Figure 3 | Identiﬁcation of the covalent dipeptidyl enzyme intermediate with the variant Y202F. (a) PMF analysis of trypsin-digested Y202F variant pre-
incubated with two equivalents of Phe-tRNAPhe for 30 s. Arrows indicate the formation of two additional fragments that were not observed in the PMF
analysis of the trypsin-digested Y202F variant not incubated with Phe-tRNAPhe (Supplementary Fig. 9): the m/z at 2,310.12 (close-up view in solid box)
corresponds to the potential phenylalanylated fragment [27–46] and the m/z at 2,457.24 (close-up view in dashed box) corresponds to the
diphenylalanylated fragment [27–46]. The non-modiﬁed [27–46] fragment was detected at m/z 2,163.07. (b) PSD-MS/MS spectrum of m/z 2,457.24.
Both b- and y-ion series identify the amino acid sequence of the modiﬁed AlbC fragment [27–46] and identify the residue 37 as the diphenylalanylated
residue. The main daughter-ion at m/z 2,148.02 corresponds to the modiﬁed fragment [27–46] without its diphenylalanyl moiety. Note that the scale of the
2,148.02 peak differs from the others.
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some characteristics of class-Ic aaRSs regarding their interaction
with the tRNA moiety of the second substrate. Further studies
describing precisely the tRNA-binding regions on CDPSs are still
needed to clarify this issue.
This study indicates that compared with class-Ic aaRSs, CDPSs
have acquired both new active site residues and a new aminoacyl-
binding site for a second aa-tRNA substrate. This is an important
step forward in the understanding of CDPS speciﬁcity, and this
knowledge may facilitate the engineering of these enzymes to
produce a diversity of natural and unnatural cyclodipeptides.
Methods
Puriﬁcation of AlbC variants. Plasmids encoding the AlbC variants S37C, Y202F
and N40A were constructed previously4. The variant H203A was obtained via PCR
mutagenesis with oligonucleotides described in Supplementary Table 3 of the
plasmid pQE60-AlbC encoding C-terminal His6-tagged AlbC according to the
QuikChange site-directed mutagenesis method (Stratagene). Sequences were veriﬁed
by DNA sequencing. The C-terminal His6-tagged proteins were produced and
puriﬁed as described previously4. Puriﬁed proteins were quantiﬁed by ultraviolet
spectrophotometry. Protein molecular weights were veriﬁed by electrospray
ionization MS (Esquire HCT ion trap mass spectrometer (Bruker Daltonik, GmbH)).
The structural integrity of the variants was veriﬁed by far-ultraviolet circular
dichroism spectroscopy (Jasco J-815 circular dichroism spectropolarimeter).
Crystallization and structure determination. A mixture of AlbC S37C (75 mM)
and ZPCK (100 mM) was used for crystallization trials. Crystals were obtained by
the sitting drop method at 4 C (Mosquito robot, TTP Labtech), by mixing equal
volumes of protein and a solution containing 10% (W/v) PEG8000, 50mM KCl,
50mM sodium cacodylate, pH 6.0 (condition E8 of the Natrix screen, Hampton
Research). Cryoprotection was achieved by adding 25% (v/v) glycerol to the
crystallization liquor. Diffraction data were collected at 100 K (l¼ 0.984 Å) on the
Proxima-1 beamline at the SOLEIL synchrotron equipped with a Pilatus detector.
Diffraction images were analysed with X-ray Detector Software (XDS)25 and the
data were processed with programmes of the CCP4 package26. The ﬁnal data set
was at a resolution of 2.9 Å (Table 1). The structure was solved by molecular
replacement with PHASER27 and the structure of AlbC4 was used as a search
model (PDB 3OQV). Density for ZPCK connected to C37 was easily identiﬁed. The
geometry restraints ﬁle for the ZPCK-modiﬁed cysteinyl residue was created with
eLBOW and REEL28. The structure was reﬁned through several cycles of manual
rebuilding with COOT29 and positional reﬁnement with BUSTER (BUSTER
version 2.10.0., Global Phasing Ltd, Cambridge, UK). A ﬁnal round of reﬁnement
was performed with single group translation/libration/screw (TLS) parameters. The
ﬁnal model (free R¼ 0.253, R¼ 0.201) contained all AlbC residues, including the
ZPCK-modiﬁed C37, with the exception of residues 1–9 at the amino terminus and
residues 234–239 at the C terminus, as well as three water molecules. Reﬁnement
statistics are given in Table 1. A model of the dipeptidyl enzyme was generated to
facilitate interpretation by building a diphenylalanyl-modiﬁed serine residue from
the reﬁned ZPCK-modiﬁed cysteine coordinates and optimizing the geometry with
eLBOW28.
Acyl tRNA synthesis. Production and puriﬁcation of Escherichia coli tRNAs were
performed as described previously30. tRNAPhe was expressed from pBSTNAV2/
tRNAPhe (ref. 31) and tRNALeuCAG from pBSTNAV2/tRNALeuCAG (ref. 21). The
concentration of aminoacylated tRNA was determined from plateau charging
experiments21.
Identiﬁcation of the covalent peptidyl-enzyme species. A total of 12mM
(2 equivalents) of Phe-tRNAPhe was mixed with 6 mM of AlbC (or variant) in 20ml
of the reaction buffer containing 50mM HEPES-KOH pH 7.0 and 50mM KCl.
After 30 s of incubation, a 5-ml aliquot was removed and submitted to hydrolysis
for further analysis by PMF: the samples were diluted up to 10 ml in 50mM
NH4AcO2, pH 8.0, and 1 ml of porcine trypsin (Promega) (400 ng ml 1) was added.
Trypsinolysis was performed at 50 C up to 10min. Sample digests were then
acidiﬁed by 1.25% triﬂuoroacetic acid (TFA) in water, desalted and concentrated by
C18 ziptip and spotted with 4-HCCA matrix solution (10mgml 1 in 49.8/49.8/
0.4: CH3CN/H2O/TFA: v/v/v) on a matrix-assisted laser desorption/ionization
plate. The remaining reaction sample was analysed by LC–MS (ESI-ion trap
Esquire HCT Bruker Daltonics) with a linear gradient of acetonitrile/water with
0.1% TFA (ProSwift RP-4H monolithic column from Thermo-Scientiﬁc).
MS and MS/MS spectra were registered with a 4800 MALDI-TOF/TOF mass
spectrometer (Applied Biosystems, Foster City, USA) in positive reﬂectron mode.
Each MS spectrum was the result of 1,000 laser shots and trypsin autolysis
fragments were used as internal standards for calibration.
MS/MS analyses were performed under PSD (post-source decay) mode. Each
MS/MS spectrum was the result of 10,000 shots. The sequence of the trypsin
fragments was identiﬁed with Data Explorer processing software (Version 4.9,
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Figure 4 | Proposed mechanism for cyclodipeptide synthesis by CDPSs during which a covalent acyl- and subsequently dipeptidyl-AlbC are formed.
The formation of cFF catalysed by AlbC is shown; the ﬁrst and second incorporated phenylalanyl moieties of Phe-tRNAPhe are highlighted in blue and
yellow, respectively. Possible interactions are indicated by dashed lines and predicted distances are labelled. Step 4 is illustrated by the model of the
diphenylalanyl enzyme intermediate in which residues involved in the catalysis are shown as blue sticks (see Supplementary Fig. 6). The amino groups of
Phe-tRNAs (Steps 1 and 3) are assumed to be in their NH2 state, as described in the context of the ribosome
32. The amino groups of the aminoacyl- (Steps
2 and 3) and dipeptidyl intermediates (Steps 4 and 5) are expected to be in their NH3
þ state33; these protonation states are supported by pKa values
predicted with the heuristic pKa calculation software PROPKA20 (10.4 and 11.2, respectively).
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Applied Biosystems) to assign the potential chemical modiﬁcations of the serine or
cysteine residues.
AlbC S37C-ZPK characterization. AlbC S37C (0.04 mgml 1) was incubated with
100 equivalents of ZPCK in Tris–HCl 100mM, pH 8 for 3 h. The sample was
loaded onto a Ni-NTA agarose resin (Qiagen) to wash out the excess ZPCK. The
resin was washed with a large excess of 50mM HEPES-KCl, 50mM KCl buffer.
A 5-ml aliquot of resin was removed, diluted up to 10 ml in 50mM NH4AcO2, pH
8.0, and submitted to trypsin digestion for PMF as described for the identiﬁcation
of the peptidyl enzyme intermediate.
Cyclodipeptide-synthesizing activity assay. The CDPS activity of AlbC and
AlbC variants was measured with an end point assay, as performed previously21.
Activity was determined in a coupled assay containing aaRSs to generate in situ the
aa-tRNA substrates. The assay was performed in a buffer containing 50mM
HEPES-KOH, pH 7.5, 50mM KCl, 15mM MgCl2, 0.1mM EDTA, 2mM ATP,
10mM b-mercaptoethanol), with 50 mM Phe and Leu, 1 mM PheRS and LeuRS,
150 nM AlbC or 1.5 mM AlbC variant, 0.75 mM Phe-tRNAPhe and 0.66 mM Leu-
tRNALeuCAG. The reaction was carried out at 30 C with a preincubation of 15min
with the aaRSs for the synthesis of aa-tRNAs before the addition of AlbC or AlbC
variant. The enzymatic reaction was initiated by the addition of AlbC or AlbC
variant. The reaction was stopped after 21min by acidiﬁcation with 2% TFA, and
mixed with known concentrations of stable isotope internal standards (13C9,15N-
labelled cFF and cFL solutions), before cFF and cFL quantiﬁcation by LC–MS as
described previously7.
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